Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0008 USD | -96.36% | -96.36% | -99.07% |
Jan. 17 | Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023 | CI |
2023 | Innovation1 Biotech Inc. announced that it has received $0.15 million in funding | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Frederick Pierce
CEO | Chief Executive Officer | 63 | 22-09-08 |
Charles Allen
BRD | Director/Board Member | 49 | 22-12-04 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Frederick Pierce
CEO | Chief Executive Officer | 63 | 22-09-08 |
Charles Allen
BRD | Director/Board Member | 49 | 22-12-04 |
Director/Board Member | 70 | 22-12-04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 5,389,028 | 0 | 0 | 33.95 % |
Stock B | 0 | 2,694,514 | 0 | 0 | |
Stock C | 1 | 22,470,239 | 7,628,399 ( 33.95 %) | 0 |
Company contact information
Innovation1 Biotech, Inc.
7 Grand View Avenue
02143, Somerville
+
1st Jan change | Capi. | |
---|---|---|
-99.07% | 17.98K | |
+104.69% | 4.45B | |
+1.70% | 1.01B | |
+2.19% | 981M | |
+41.91% | 872M | |
+28.21% | 853M | |
+1.72% | 663M | |
+0.54% | 610M | |
-.--% | 600M | |
+27.56% | 560M |
- Stock Market
- Equities
- IVBT Stock
- Company Innovation1 Biotech Inc.